Effects of Photobiomodulation in Children With Down Syndrome and Possible Sleep Bruxism
Effects of Photobiomodulation in Children With Down Syndrome and Possible Sleep Bruxism: Protocol For A Randomized, Controlled, Blind, Clinical Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
-
São Paulo, Brazil, 01525-000
- Nove de Julho University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Children and adolescents with a diagnosis of Down syndrome
- Four to 17 years of age
- Bruxism, based on parental reports of the occurrence of grinding the teeth, incisal and/or occlusal tooth wear following the criteria of the American Academy of Sleep Medicine (AASM) and the questionnaire for the evaluation of bruxism validated by Serra Negra et al. (2014) and a systematic review performed by Manfredini et al. (2013).
Exclusion Criteria:
- Use of muscle relaxant
- Temporomandibular disorder
- Undergoing other therapy for bruxism
- Other associated neurological diseases
- Cognitive deficit that impedes understanding the evaluations.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Group Intervention
Treatment with LED clusters.
|
Each LED board contains six (6) LEDs with a wavelength of 660nm and a duration of seven (7) minutes in each muscle.
The treatment was carried out in a total of four (4) sessions, one (1) session per week.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of electromyography of masticatory muscles
Time Frame: Baseline and immediately after each the procedure.
|
The activation of the masseter muscles (right and left) and anterior temporalis (right and left) has analyses of electrical activities that were collected by means of the BTS TMJOINT electromyograph from BTS Engineering with 6 channels, 4 of which are used, containing a bioelectric signal amplifier, wireless data transmission (wireless system) and disposable bipolar surface electrodes (Ag/AgCl - Medical Trace®) with 10 mm in diameter.
The EMG signal was amplified with a gain of 2000 times and filtered within a frequency of 20-450 Hz.
The impedance and common rejection mode of the equipment are >1015 Ω//0.2 pF and 60/10Hz 92 dB.
|
Baseline and immediately after each the procedure.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Orofacial Evaluation Through NOT-S (score from 0 to 12)
Time Frame: Baseline and immediately after each the procedure.
|
The following functions are addressed during the interview: (I) sensory function, (II) breathing, (III) habits, (IV) chewing and swallowing, (V) drooling and (VI) dryness of the mouth.
The following functions are evaluated during the physical examination: (1) face at rest, (2) nose breathing, (3) facial expression, (4) masticatory muscle and jaw function, (5) oral motor function and (6) speech.
For the evaluation of orofacial dysfunction during the clinical examination, the participants will be asked to perform tasks for each item in accordance with the illustrated manual.
Each item has criteria for the respective function.
A "YES" response or task the meets the criteria for compromised function will be scored 1 point, indicating dysfunction in the respective domain.
A "NO" response or task that does not meet the criteria will be scored zero.
The total is the sum of the points of all domains and ranges from 0 to 12, with higher scores denoting greater orofacial disfunction.
|
Baseline and immediately after each the procedure.
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neurologic Manifestations
- Stomatognathic Diseases
- Nervous System Diseases
- Mental Disorders
- Genetic Diseases, Inborn
- Tooth Diseases
- Neurobehavioral Manifestations
- Sleep Wake Disorders
- Congenital Abnormalities
- Abnormalities, Multiple
- Intellectual Disability
- Chromosome Disorders
- Parasomnias
- Bruxism
- Down Syndrome
- Sleep Bruxism
Other Study ID Numbers
Other Study ID Numbers
- DownSyndrome
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.